Javascript must be enabled to continue!
Impact of cervical human papillomavirus infection on pregnancy outcomes of intrauterine insemination in unexplained infertility patients
View through CrossRef
Abstract
Background
Intrauterine insemination (IUI) is a common treatment for couples with unexplained infertility. However, the impact of human papillomavirus (HPV) infection on IUI outcomes remains uncertain. This study therefore aims to investigate whether HPV infection in women with unexplained infertility affects pregnancy outcomes following IUI.
Methods
This retrospective cohort study, which adhered to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines, analyzed 435 women with unexplained infertility who underwent intrauterine insemination (IUI) at the Reproductive Centre of Sun Yat-Sen Memorial Hospital between January 2018 and December 2022.Based on their HPV infection status within one year prior to treatment, participants were categorized into an HPV-positive group (n = 33) and an HPV-negative group (n = 402). We first utilized univariate analysis to compare the baseline characteristics and assisted conception data between the two groups. Subsequently, a multivariate logistic regression model was employed to further assess the independent correlation between HPV infection and the key clinical outcome of live birth.
Results
Sixty-six women achieved live births and 369 did not. Cervical cytological abnormalities were more frequent in the HPV-positive group (25.0% vs. 1.3%, P < 0.05). No significant differences were found in live birth, clinical pregnancy, biochemical pregnancy, early abortion, ectopic pregnancy, or cesarean section rates between HPV groups (P > 0.05). Preterm birth was significantly higher in HPV-positive women (66.7% vs. 4.8%, P < 0.05). After adjusting for confounders, HPV infection was not independently associated with live birth (P > 0.05). Increased maternal age reduced the odds of live birth (OR 0.946, 95% CI 0.932–0.961, P = 0.000), higher anti-Müllerian hormone (AMH) improved live birth odds (OR 1.096, 95% CI 1.022–1.176, P = 0.011), and husband’s smoking decreased live birth odds (OR 0.385, 95% CI 0.187–0.793, P = 0.010).
Conclusion
HPV infection does not significantly influence IUI pregnancy outcomes in women with unexplained infertility
Trial registration
This study was supported in part by the Sun Yat-Sen Clinical Research 5010 Program (grant number SYS-5010-202410), Guangzhou Science and Technology Program (grant number 2024A03J0983),in October 2024.
Springer Science and Business Media LLC
Title: Impact of cervical human papillomavirus infection on pregnancy outcomes of intrauterine insemination in unexplained infertility patients
Description:
Abstract
Background
Intrauterine insemination (IUI) is a common treatment for couples with unexplained infertility.
However, the impact of human papillomavirus (HPV) infection on IUI outcomes remains uncertain.
This study therefore aims to investigate whether HPV infection in women with unexplained infertility affects pregnancy outcomes following IUI.
Methods
This retrospective cohort study, which adhered to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines, analyzed 435 women with unexplained infertility who underwent intrauterine insemination (IUI) at the Reproductive Centre of Sun Yat-Sen Memorial Hospital between January 2018 and December 2022.
Based on their HPV infection status within one year prior to treatment, participants were categorized into an HPV-positive group (n = 33) and an HPV-negative group (n = 402).
We first utilized univariate analysis to compare the baseline characteristics and assisted conception data between the two groups.
Subsequently, a multivariate logistic regression model was employed to further assess the independent correlation between HPV infection and the key clinical outcome of live birth.
Results
Sixty-six women achieved live births and 369 did not.
Cervical cytological abnormalities were more frequent in the HPV-positive group (25.
0% vs.
1.
3%, P < 0.
05).
No significant differences were found in live birth, clinical pregnancy, biochemical pregnancy, early abortion, ectopic pregnancy, or cesarean section rates between HPV groups (P > 0.
05).
Preterm birth was significantly higher in HPV-positive women (66.
7% vs.
4.
8%, P < 0.
05).
After adjusting for confounders, HPV infection was not independently associated with live birth (P > 0.
05).
Increased maternal age reduced the odds of live birth (OR 0.
946, 95% CI 0.
932–0.
961, P = 0.
000), higher anti-Müllerian hormone (AMH) improved live birth odds (OR 1.
096, 95% CI 1.
022–1.
176, P = 0.
011), and husband’s smoking decreased live birth odds (OR 0.
385, 95% CI 0.
187–0.
793, P = 0.
010).
Conclusion
HPV infection does not significantly influence IUI pregnancy outcomes in women with unexplained infertility
Trial registration
This study was supported in part by the Sun Yat-Sen Clinical Research 5010 Program (grant number SYS-5010-202410), Guangzhou Science and Technology Program (grant number 2024A03J0983),in October 2024.
Related Results
Playing Pregnancy: The Ludification and Gamification of Expectant Motherhood in Smartphone Apps
Playing Pregnancy: The Ludification and Gamification of Expectant Motherhood in Smartphone Apps
IntroductionLike other forms of embodiment, pregnancy has increasingly become subject to representation and interpretation via digital technologies. Pregnancy and the unborn entity...
Analysis of influencing factors of clinical pregnancy rate in second cycle intrauterine insemination
Analysis of influencing factors of clinical pregnancy rate in second cycle intrauterine insemination
To explore the factors influencing the clinical pregnancy rate in the Reproductive Center of the Affiliated Hospital of North Sichuan Medical College in the second cycle, a retrosp...
Association between trigger-intrauterine insemination interval, ovulation trigger agent, and clinical pregnancy in intrauterine insemination cycles: a 300-case analysis
Association between trigger-intrauterine insemination interval, ovulation trigger agent, and clinical pregnancy in intrauterine insemination cycles: a 300-case analysis
Background: Intrauterine insemination (IUI) is a commonly employed first-line treatment for couples with unexplained infertility and mild male factor infertility due to its simplic...
P-327 Intrauterine fluid in patients with cesarean section defects in association with ivf outcomes
P-327 Intrauterine fluid in patients with cesarean section defects in association with ivf outcomes
Abstract
Study question
This study evaluate the effect of cesarean section scar defects associated with intrauterine fluid durin...
Nutrition in pregnancy
Nutrition in pregnancy
SUMMARY
INTRODUCTION
PHYSIOLOGICAL CHANGES DURING PREGNANCY
Changes in body composition and weight gain
Changes in blood composition
Metabolic changes and adaptive responses
K...
Causes of Infertility among the Couples Who are Attending the Infertility OPD of BSMMU
Causes of Infertility among the Couples Who are Attending the Infertility OPD of BSMMU
Introduction: Infertility may be defined as inability to conceive within one year of unprotected regular coitus. Approximately 85 – 90% of healthy young couples conceive within 1 y...
Outcome of treatment with letrozole versus gonadotrophins stimulated IUI (Intrauterine Insemination) in the management of unexplained infertility.
Outcome of treatment with letrozole versus gonadotrophins stimulated IUI (Intrauterine Insemination) in the management of unexplained infertility.
Objective: To compare the outcome of treatment in patients with primary unexplained infertility with gonadotrophin v/s letrozole stimulated IUI (intrauterine insemination). Study D...
Idiopathic infertility
Idiopathic infertility
Abstract
There are a multitude of disorders that lead to hypogonadism and infertility, but despite this the largest group of infertile men are those diagnosed as suf...

